Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbiopharmadive.com
BioPharma Dive - Latest News
Get the latest updates from BioPharma Dive - Latest News directly as they happen.
Follow now 125 followers
Latest posts
Last updated about 4 hours ago
Cancer drugmaker LaNova to sell to China’s Sino Biopharm
about 5 hours ago
Sino Biopharmaceuticals plans to pay up to nearly $951 million to acquire...
Hengrui, Kailera say dual-acting obesity shot succeeds in China study
about 5 hours ago
The results position Hengrui to seek approval of the Zepbound-like drug in...
Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug
about 5 hours ago
NHS England has agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile...
AstraZeneca blood pressure drug succeeds in late-stage trial
1 day ago
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could...
Private equity firms back PCI Pharma in strategic bet on drug production
1 day ago
The CDMO, which has been owned by different private investors over the...
FDA rejects Ultragenyx gene therapy over manufacturing concerns
1 day ago
While the complete response letter derails a near-term clearance, one analyst described...
Takeda to seek approval of new kind of narcolepsy drug after study data
1 day ago
Positive late-stage study results position the company to file for clearance of...
From data to decisions: How pharma can move faster without sacrificing trust
1 day ago
Pharma's speed advantage depends on trust. Is your data foundation strong enough?
Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update
4 days ago
Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile...
With Verona deal, Merck wagers on strength of lung drug’s patents
4 days ago
The main patent for Ohtuvayre, the COPD drug at the heart of...
FDA turns back Capricor’s Duchenne cell therapy
4 days ago
The company said it was “surprised” by the decision, which followed the...
Soleno sales of new Prader-Willi drug rise faster than expected
5 days ago
Preliminary quarterly sales figures for Vykat surpassed Wall Street estimates, but shares...